Cell and gene therapy's protein expression system demand — the extraordinary commercial development of viral vector-based gene therapies (AAV, lentiviral, adenoviral), CAR-T cell therapies, and mRNA therapeutics — creating novel protein expression system requirements that go beyond traditional recombinant protein manufacturing toward production of viral capsid proteins, envelope...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek